Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fluvastatin.

J M Lawrence1, J P D Reckless

  • 1Clinical Research Fellow, Diabetes and Lipid Research, Wolfson Centre, Royal United Hospital, Bath, UK. mpsjml@bath.ac.uk

Expert Opinion on Pharmacotherapy
|November 20, 2002
PubMed
Summary
This summary is machine-generated.

Fluvastatin effectively lowers cholesterol and reduces coronary heart disease events, especially in high-risk patients. This synthetic statin is well-tolerated with a low risk of serious side effects like rhabdomyolysis.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Two Cases of Puerperal Peritonitis.

Western journal of medicine and surgery·2024
Same author

Kondo quasiparticle dynamics observed by resonant inelastic x-ray scattering.

Nature communications·2022
Same author

A typology of North Sea oil and gas platforms.

Scientific reports·2022
Same author

Association of glucose metabolism and blood pressure during pregnancy with subsequent maternal blood pressure.

Journal of human hypertension·2021
Same author

Association between fear of hypoglycemia and physical activity in youth with type 1 diabetes: The SEARCH for diabetes in youth study.

Pediatric diabetes·2020
Same author

Socio-economic, demographic, and clinical correlates of poor glycaemic control within insulin regimens among children with Type 1 diabetes: the SEARCH for Diabetes in Youth  Study.

Diabetic medicine : a journal of the British Diabetic Association·2019
Same journal

Pharmacotherapeutic interventions for pediatric ulcerative colitis.

Expert opinion on pharmacotherapy·2026
Same journal

The rise and fall of TRPV1-targeted analgesia in osteoarthritis: a critical appraisal.

Expert opinion on pharmacotherapy·2026
Same journal

Dopamine transporter and beyond: evolving targets and combination strategies in stimulant use disorder.

Expert opinion on pharmacotherapy·2026
Same journal

GnRH antagonists for the treatment of fibroids and adenomyosis, current evidence and future perspectives.

Expert opinion on pharmacotherapy·2026
Same journal

Pharmacotherapeutic strategies for the management of congenital adrenal hyperplasia.

Expert opinion on pharmacotherapy·2026
Same journal

Current advances in pharmacotherapeutic strategies for the treatment of complicated intra-abdominal infections.

Expert opinion on pharmacotherapy·2026
See all related articles

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Fluvastatin is the first synthetic statin.
  • Statins reduce cholesterol and coronary heart disease (CHD) events.

Purpose of the Study:

  • To evaluate the effectiveness and safety of fluvastatin in high-risk patients.
  • To assess fluvastatin's role in preventing recurrent CHD events post-percutaneous coronary interventions.

Main Methods:

  • The Lescol Intervention Prevention Study established fluvastatin's effectiveness.
  • Analysis of patient data regarding cholesterol reduction and CHD event rates.

Main Results:

  • Fluvastatin effectively reduces total and low-density lipoprotein cholesterol.
  • Early statin use, including fluvastatin, reduces recurrent CHD events in high-risk patients.
  • Fluvastatin is well-tolerated with infrequent liver enzyme abnormalities and a low risk of myositis and rhabdomyolysis.

Conclusions:

  • Fluvastatin is a safe and effective option for managing hypercholesterolemia.
  • It offers a favorable safety profile with low potential for drug interactions and serious side effects.
  • Fluvastatin provides a valuable treatment choice for high-risk cardiovascular patients.